PYRAZOLO[1,5-A]PYRIMIDINE COMPOUND FOR THE TREATMENT OF DERMAL DISORDERS

Provided is a pyrazolo[1,5-a]pyrimidine compound represented by the general formula [I]: wherein each symbol is as defined in the description, or a salt thereof, having PAR2 inhibitory activity, and a pharmaceutical composition comprising the same. L'invention concerne un composé pyrazolo[1,5-a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	NAKAMURA, YUICHI, MATSUDA, SATOSHI, TAKAHASHI, AKIRA, YAMAUCHI, TAKAHITO, WATANABE, KENJI, OKADA, MINORU, MENJO, YASUHIRO, HANARI, TAIKI, UEMATSU, YUKITAKA, SAITO, AKIHIRO, YAMAGUCHI, ATSUSHI, YUKI, YOHEI
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided is a pyrazolo[1,5-a]pyrimidine compound represented by the general formula [I]: wherein each symbol is as defined in the description, or a salt thereof, having PAR2 inhibitory activity, and a pharmaceutical composition comprising the same. L'invention concerne un composé pyrazolo[1,5-a]pyrimidine représenté par la formule générale [I] dans laquelle chaque symbole est tel que défini dans la description, ou un sel de celui-ci, ayant une activité inhibitrice de PAR2, et une composition pharmaceutique le comprenant.